39 related articles for article (PubMed ID: 28178752)
1. UTP23 Functions in Breast Cancer Progression and Predicts Poor Prognosis of Luminal a Breast Cancer.
Zhang S; Bai X; Li F; Ni C; Li Y; Che N; Zhao N; Zhao X; Liu T
Clin Breast Cancer; 2024 Jan; 24(1):e20-e30.e6. PubMed ID: 37880005
[TBL] [Abstract][Full Text] [Related]
2. CD301 and LSECtin glycan-binding receptors of innate immune cells serve as prognostic markers and potential predictors of immune response in breast cancer subtypes.
Wegscheider AS; Wojahn I; Gottheil P; Spohn M; Käs JA; Rosin O; Ulm B; Nollau P; Wagener C; Niendorf A; Wolters-Eisfeld G
Glycobiology; 2024 Apr; 34(3):. PubMed ID: 38206856
[TBL] [Abstract][Full Text] [Related]
3. Impact of immunohistochemistry staining conditions on the incidence of human epidermal growth factor receptor 2 (HER2)-low breast cancer.
Kim MC; Kwon SY; Jung HR; Bae YK
Virchows Arch; 2024 May; ():. PubMed ID: 38758231
[TBL] [Abstract][Full Text] [Related]
4. Inferring gene regulatory network from single-cell transcriptomes with graph autoencoder model.
Wang J; Chen Y; Zou Q
PLoS Genet; 2023 Sep; 19(9):e1010942. PubMed ID: 37703293
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value and multifaceted roles of tetraspanin CD9 in cancer.
Ondruššek R; Kvokačková B; Kryštofová K; Brychtová S; Souček K; Bouchal J
Front Oncol; 2023; 13():1140738. PubMed ID: 37007105
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant chemotherapy endows CD9 with prognostic value that differs between tumor and stromal areas in patients with pancreatic cancer.
Han X; Zhang WH; Gao HL; Li TJ; Xu HX; Li H; Li PC; Wang X; Yu XJ; Wang WQ; Liu L
J Clin Lab Anal; 2022 Jul; 36(7):e24517. PubMed ID: 35622458
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of CD9 in Solid Tumor: A Systematic Review and Meta-Analysis.
Zeng P; Si M; Sun RX; Cheng X; Li XY; Chen MB
Front Oncol; 2021; 11():764630. PubMed ID: 34868985
[TBL] [Abstract][Full Text] [Related]
8. Analysing "tear-drop" prints of acute promyelocytic leukemia (APML): immunophenotypic prognostication of APML by FCM.
Siraj F; Tanwar P; Singh A; Rishi B; Ranjan A; Chopra A; Rai S; Bakhshi S; Misra A
Am J Blood Res; 2021; 11(4):446-457. PubMed ID: 34540354
[TBL] [Abstract][Full Text] [Related]
9. Increased CD9 expression predicts favorable prognosis in human cancers: a systematic review and meta-analysis.
Koh HM; Jang BG; Lee DH; Hyun CL
Cancer Cell Int; 2021 Sep; 21(1):472. PubMed ID: 34493282
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical Expressions of Senescence-Associated Secretory Phenotype and Its Association With Immune Microenvironments and Clinicopathological Factors in Invasive Breast Cancer.
Park MH; Choi JE; Kim JR; Bae YK
Pathol Oncol Res; 2021; 27():1609795. PubMed ID: 34267603
[TBL] [Abstract][Full Text] [Related]
11. CD9, a tetraspanin target for cancer therapy?
Lorico A; Lorico-Rappa M; Karbanová J; Corbeil D; Pizzorno G
Exp Biol Med (Maywood); 2021 May; 246(9):1121-1138. PubMed ID: 33601913
[TBL] [Abstract][Full Text] [Related]
12. Tetraspanin CD9 is Regulated by miR-518f-5p and Functions in Breast Cell Migration and In Vivo Tumor Growth.
Bond DR; Kahl R; Brzozowski JS; Jankowski H; Naudin C; Pariyar M; Avery-Kiejda KA; Scarlett CJ; Boucheix C; Muller WJ; Ashman LK; Cairns MJ; Roselli S; Weidenhofer J
Cancers (Basel); 2020 Mar; 12(4):. PubMed ID: 32224917
[TBL] [Abstract][Full Text] [Related]
13. Expression of tetraspanins NET-6 and CD151 in breast cancer as a potential tumor biomarker.
Jiang L; Zhang X; Geradts J; Wei Q; Hochwald S; Xu H; Huang H
Clin Exp Med; 2019 Aug; 19(3):377-384. PubMed ID: 31004251
[TBL] [Abstract][Full Text] [Related]
14. CD9 Expression in Tumor Cells Is Associated with Poor Prognosis in Patients with Invasive Lobular Carcinoma.
Baek J; Jang N; Choi JE; Kim JR; Bae YK
J Breast Cancer; 2019 Mar; 22(1):77-85. PubMed ID: 30941235
[TBL] [Abstract][Full Text] [Related]
15. CD9 in acute myeloid leukemia: Prognostic role and usefulness to target leukemic stem cells.
Touzet L; Dumezy F; Roumier C; Berthon C; Bories C; Quesnel B; Preudhomme C; Boyer T
Cancer Med; 2019 Mar; 8(3):1279-1288. PubMed ID: 30740913
[TBL] [Abstract][Full Text] [Related]
16. Validation of the pathological prognostic staging system proposed in the revised eighth edition of the AJCC staging manual in different molecular subtypes of breast cancer.
Jang N; Choi JE; Kang SH; Bae YK
Virchows Arch; 2019 Feb; 474(2):193-200. PubMed ID: 30474738
[TBL] [Abstract][Full Text] [Related]
17. Antitumor Immunity Is Controlled by Tetraspanin Proteins.
Schaper F; van Spriel AB
Front Immunol; 2018; 9():1185. PubMed ID: 29896201
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of CD9 expression differs between tumour cells and stromal immune cells, and depends on the molecular subtype of the invasive breast carcinoma.
Kwon HJ; Choi JE; Kang SH; Son Y; Bae YK
Histopathology; 2017 Jun; 70(7):1155-1165. PubMed ID: 28178752
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of interferon regulating factor 4 (IRF4) in node-negative breast cancer.
Heimes AS; Madjar K; Edlund K; Battista MJ; Almstedt K; Gebhard S; Foersch S; Rahnenführer J; Brenner W; Hasenburg A; Hengstler JG; Schmidt M
J Cancer Res Clin Oncol; 2017 Jul; 143(7):1123-1131. PubMed ID: 28251349
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
